0001562180-22-002137.txt : 20220302 0001562180-22-002137.hdr.sgml : 20220302 20220302182200 ACCESSION NUMBER: 0001562180-22-002137 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220228 FILED AS OF DATE: 20220302 DATE AS OF CHANGE: 20220302 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Jones David Scott CENTRAL INDEX KEY: 0001779458 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51122 FILM NUMBER: 22705638 MAIL ADDRESS: STREET 1: C/O EYEPOINT PHARMACEUTICALS, INC., STREET 2: 480 PLEASANT STREET, SUITE A210 CITY: WATERTOWN STATE: MA ZIP: 02472 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: EyePoint Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001314102 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 262774444 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 480 PLEASANT STREET STREET 2: SUITE B300 CITY: WATERTOWN STATE: MA ZIP: 02472 BUSINESS PHONE: 617-926-5000 MAIL ADDRESS: STREET 1: 480 PLEASANT STREET STREET 2: SUITE B300 CITY: WATERTOWN STATE: MA ZIP: 02472 FORMER COMPANY: FORMER CONFORMED NAME: pSivida Corp. DATE OF NAME CHANGE: 20080619 FORMER COMPANY: FORMER CONFORMED NAME: pSivida LTD DATE OF NAME CHANGE: 20050111 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2022-02-28 false 0001314102 EyePoint Pharmaceuticals, Inc. EYPT 0001779458 Jones David Scott C/O EYEPOINT PHARMACEUTICALS, INC. 480 PLEASANT STREET WATERTOWN MA 02472 false true false false SVP & Chief Commercial Officer Common Stock 2022-02-28 4 M false 4105.00 0.00 A 16729.00 D Common Stock 2022-02-28 4 F false 1130.00 9.95 D 15599.00 D Restricted Stock Units 0.00 2022-02-28 4 M false 4105.00 0.00 D Common Stock 4105.00 0.00 D No shares were sold - these shares were withheld by the issuer to satisfy tax withholding requirements in connection with the Reporting Person's exercise of his withholding right following the vesting of the restricted stock units The restricted stock units vested in three equal installments on the following dates: 6.30.2020, 2.28.2021 and 2.28.2022. /s/ Ron Honig, Attorney-in-Fact 2022-03-02